Description
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for hydrocortisone on the Prescription Drug List (PDL). Only the Human part of the PDL is to be revised; the listing for Veterinary use will remain unchanged.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Hydrocortisone | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Hydrocortisone | HTML | Open resource |